Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-031378

EVP & Chief Commercial Officer sold 700 shares at an average $113.67 ($79,572)

From the SEC's structured data for this filing

Trades in this filing

Harris Erik · EVP & Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-06 Sale : show line 1 in the form −307 $113.68 $34,900 27,110 D
2021-05-07 Sale : show line 2 in the form −393 $113.67 $44,672 26,717 D
Open-market sales · 700 sh · avg $113.67 · $79,572
Loading xslF345X03/doc4.xml…